BioSpace News Archive

RxRevu, the nation’s leading provider of prescription decision support solutions, has partnered with athenahealth, a leading supplier of network-enabled software and services for medical groups and health systems nationwide, to deploy SwiftRx® Direct™ – RxRevu’s Real-Time Prescription Benefit solution – within athenahealth’s electronic hea

Recce Pharmaceuticals Ltd (ASX: RCE), the Company developing New Classes of Synthetic Anti-Infectives, is pleased to announce the Board of Directors has unanimously appointed Michele Dilizia to the role of Chief Scientific Officer.

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced plans to develop two new sterile filling lines in Singapore to extend capacity to the Asia-Pacific region for the development a

WAKIX is the first and only non-scheduled treatment approved for excessive daytime sleepiness or cataplexy in adult patients with narcolepsy

Medeor Therapeutics, Inc. , a clinical-stage company dedicated to the development and commercialization of immunotherapies for transplantation, today announced the appointment of Daniel Brennan, MD, as Chief Medical Officer. In his role, Dr. Brennan will oversee the clinical development program fo

Moderna, Inc. , (Nasdaq:MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that it has received written confirmation from the European Medicine Agency (EMA) that mRNA-1273, the Company’s vaccine candidate ag

Albany Molecular Research, Inc., ( AMRI ), a leading global provider of advanced contract research, development and manufacturing solutions, today announced that its CEO and CFO will present a corporate overview at the Jefferies 2020 Virtual London Healthcare Conference. The presentation, to be delivered by CEO John Ratliff and CFO Jason Knoblauch , will be recorded and made available on AMRI’s website. AMRI’s execu

Anika Chebrolu Takes Home Top Prize and Improving Lives Award at This Year’s 3M Young Scientist Challenge

Perrigo Company plc (NYSE; TASE: PRGO), a leading provider of Quality, Affordable Self-Care Products, today announced that it will release its third quarter financial results on Wednesday, November 4, 2020 . The Company will also host a conference call beginning at 8:00 a.m. (EST) .

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act) with respect to Gilead’s cash tender offer for Immunomedics, Inc. expired at 11:59 p.m. on October 13, 2020. On September 25, 2020, Gilead and Immunomedics filed the Premerger Notification and Report Forms required under the HSR Act with the Federal Trade